Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans

Major Depressive Disorder Clinical Trial

Official title:

Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01851967
• Other study ID #: 2012-P-002340
• Status: Completed
• Phase: N/A
• First received: January 8, 2013
• Last updated: November 30, 2016
• Start date: September 2014
• Est. completion date: November 2016

Study information

• Verified date: November 2016
• Source: Massachusetts General Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

This study aims to evaluate efficacy and acceptability of the Chinese language version of MoodGYM as a therapeutic intervention in treating symptoms of depression in community dwelling Chinese Americans in the Boston area.

Hypothesis 1: Participants enrolled in MoodGYM will show a significant decrease in depressive symptoms after completion of the 5 modules.

Hypothesis 2: Participants enrolled in MoodGYM will show significantly improved dysfunctional thinking.

Hypothesis 3: Participants enrolled in MoodGym will rate this program as culturally acceptable.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 112
• Est. completion date: November 2016
• Est. primary completion date: December 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Resident of the US, but self-identified as Chinese origin

• At least 18 years of age

• Proficiency in Chinese, including the ability to read Chinese

• Access to computer and internet

• Scores > 10 on the Chinese bilingual patient health questionnaire -9 item (PHQ-9)

Exclusion Criteria:

• Current ongoing psychiatric or psychological treatment

• Using illicit drugs or consumption > 3 standard drinks in a day

• Currently experiencing a psychotic illness

• Past or current history of schizophrenia or bipolar disorder

• ECT during the last year

• Current active suicidal or self-injurious potential necessitating immediate face-to-face treatment

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Depression
• Depressive Disorder
• Depressive Disorder, Major
• Major Depressive Disorder

Intervention

Other:
• MoodGYM
MoodGYM, a publicly-available online CBT program developed by the Centre for Mental Health Research at The Australian National University has been shown by multiple studies to be effective in reducing symptoms of depression. MoodGYM consists of five interactive modules. Participants will be asked to complete one module each week and progress through the program sequentially.

Locations

Country	Name	City	State
China	Ying Wang	Beijing
United States	Massachusetts General Hospital Depression Clinical and Research Program	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Massachusetts General Hospital

Countries where clinical trial is conducted

United States,  China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Center for Epidemiologic Studies Depression Scale (CES-D)	The CES-D scale is a short self-report scale designed to measure depressive symptomatology in the general population. Each of the 20 items in this instrument is assigned one value of 0, 1, 2 or 3. High scores on the CES-D indicate high levels of distress.	Weeks 0, 6 (pre/post)	No

External Links

•   MoodGYM (English version)